Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 46,016 | 68,125 | 35,597 | 36,505 | 29,070 |
| Cost of Goods | 1,131 | 1,108 | 486 | 448 | 483 |
| Gross Profit | 44,885 | 67,017 | 35,111 | 36,057 | 28,587 |
| Operating Expenses | 70,006 | 78,788 | 83,460 | 89,096 | 85,446 |
| Operating Income | -24,990 | -11,663 | -47,863 | -52,591 | -56,376 |
| Interest Expense | 8,420 | 5,401 | 4,946 | 5,252 | 5,228 |
| Other Income | 3,249 | 128,666 | -726 | -92 | 311 |
| Pre-tax Income | -30,161 | 111,602 | -53,535 | -57,935 | -61,293 |
| Income Tax | -2,334 | 1,754 | 252 | 1,934 | -5,842 |
| Net Income Continuous | -27,827 | 109,848 | -53,787 | -59,869 | -55,451 |
| Net Income | $-27,827 | $109,848 | $-53,787 | $-59,869 | $-55,451 |
| EPS Basic Total Ops | -0.14 | 0.57 | -0.28 | -0.33 | -0.29 |
| EPS Basic Continuous Ops | -0.14 | 0.57 | -0.28 | -0.32 | -0.29 |
| EPS Diluted Total Ops | -0.14 | 0.56 | -0.28 | -0.33 | -0.29 |
| EPS Diluted Continuous Ops | -0.14 | 0.56 | -0.28 | -0.32 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.14 | 0.57 | -0.28 | -0.32 | -0.29 |
| EBITDA(a) | $-20,673 | $-7,883 | $-44,343 | $-48,855 | $-53,119 |